Keyphrases
Co-agonist
25%
Disease States
25%
Epilepsy
25%
Gene Knockout Mice
25%
Hit Compound
25%
IC50 Value
25%
In Silico Screening
25%
In Vitro Evaluation
25%
Inhibitory Activity
25%
Neurodegeneration
25%
Neurodegenerative Diseases
25%
Neurotoxicity
25%
NMDA-type Glutamate Receptor
75%
Overactivation
100%
Physiological Function
25%
Protective Effect
25%
Recombinant
25%
Serine Racemase
100%
Serine Racemase Inhibitors
100%
Therapeutic Strategies
25%
Neuroscience
Excitotoxicity
20%
Gene Knockout
20%
Glutamate Receptor
60%
In Vitro
40%
In Vivo
100%
N-Methyl-D-Aspartic Acid
80%
Neurodegeneration
20%
Neurodegenerative Disorder
20%
Serine
60%
Serine Racemase
100%
Medicine and Dentistry
Disease
12%
Excitotoxicity
12%
Gene Knockout
12%
Gene Targeting
12%
Glutamate Receptor
37%
IC50
12%
In Silico
12%
In Vitro
25%
N-Methyl-D-Aspartic Acid
50%
Neurodegeneration
12%
Neurodegenerative Disorder
12%
Racemase
100%
Serine
100%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
25%
Excitotoxicity
12%
Glutamate Receptor
37%
IC50
12%
Knockout Mouse
12%
N Methyl Dextro Aspartic Acid
50%
Nerve Degeneration
12%
Racemase
100%
Serine
100%